Exact Mass: 446.1763
Exact Mass Matches: 446.1763
Found 304 metabolites which its exact mass value is equals to given mass value 446.1763
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Thioproperazine
C22H30N4O2S2 (446.18100799999996)
Thioproperazine is a potent neuroleptic with antipsychotic properties. Thioproperazine has a marked cataleptic and antiapomorphine activity associated with relatively slight sedative, hypothermic and spasmolytic effects. It is virtually without antiserotonin and hypotensive action and has no antihistaminic property. It is used for the treatment of all types of acute and chronic schizophrenia, including those which did not respond to the usual neuroleptics; manic syndromes. Overdosage may result in severe extrapyramidal symptoms with dysphagia, marked sialorrhea, persistent and rapidly increasing hyperthermia, pulmonary syndrome, state of shock with pallor and profuse sweating, which may be followed by collapse and coma. LD50 in mice is 70 mg/kg I.V., 120 mg/kg I.P., 500 mg/kg S.C. and 830 mg/kg P.O. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Thioproperazine (RP 7843) is an orally active antipsychotic agent with calming, antiemetic activity. Thioproperazine is effective in promoting the release of dopamine in rat striatum. Thioproperazine can be used in studies of schizophrenia and bipolar disorder[1].
Crosatoside B
Crosatoside B is isolated from the pollen of Crocus sativus (saffron). Isolated from the pollen of Crocus sativus (saffron)
(S)-4-ethyl-4-hexanoyloxy-1,12-dihydro-4H-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14-dione|20-Hexanoyl-camptothecin|4(S)-ethyl-4-hexanoyl-1H-pyrano-[3,4:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione|O-hexanoyl-camptothecin
C26H26N2O5 (446.18416260000004)
phenethyl alcohol 8-O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside|phenethyl alcohol 8-O-beta-D-glucopyranosyl-(1->2)-O-beta-D-glucopyranoside|phenethyl alcohol beta-D-(2-O-beta-D-glucopyranosyl)glucopyranoside|phenethyl beta-D-sophoroside|phenethyl O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside|Phenethylalcohol 8-O-??-D-glucopyranosyl-(1鈥樏傗垎2)-??-D-glucopyranoside|phenylethyl-O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside
4-methoxybenzyl-O-alpha-L-rhamnopyranosyl (1->6)-beta-D-glucopyranoside
4-methoxy-2,5-dimethylphenyl alpha-L-arabinofuranosyl-(1->6)-beta-D-glucopyranoside|illoliganoside A
(1S)-1-(2-hydroxy-6-methylphenyl)ethanol 2-O-(6-O-alpha-L-arabinofuranosyl)-beta-D-glucopyranoside|juniperoside VII
4-hydroxyphenylethyl 4-O-beta-D-glucopyranosyl-(1->3)-O-alpha-L-rhamnopyranoside|strigoside
beta-hydroxy-phenylethyl-O-alpha-L-rhamnopyranosyl (1->6)-beta-D-glucopyranoside
2-phenylethyl 6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranoside|2-phenylethyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside|2-phenylethyl beta-gentiobioside|phenethyl alcohol beta-D-glucopyranosyl(1- >6)-beta-D-O-glucopyranoside|phenethyl alcohol beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|phenethyl alcohol beta-gentiobioside
C20H30O11_2-(4-Methoxyphenyl)ethyl 6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranoside
C20H30O11_2-Phenylethyl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
(2R,3R,4S,5S,6R)-2-[2-(4-methoxyphenyl)ethoxy]-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxane-3,4,5-triol
Thioproperazine
C22H30N4O2S2 (446.18100799999996)
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Thioproperazine (RP 7843) is an orally active antipsychotic agent with calming, antiemetic activity. Thioproperazine is effective in promoting the release of dopamine in rat striatum. Thioproperazine can be used in studies of schizophrenia and bipolar disorder[1].
(2R,3R,4S,5S,6R)-2-[2-(4-methoxyphenyl)ethoxy]-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxane-3,4,5-triol_major
Ala Asp Asn Gln
Ala Asp Gln Asn
Ala Glu Met Pro
Ala Glu Asn Asn
Ala Glu Pro Met
Ala Met Glu Pro
Ala Met Pro Glu
Ala Asn Asp Gln
Ala Asn Glu Asn
Ala Asn Asn Glu
Ala Asn Gln Asp
Ala Pro Glu Met
Ala Pro Met Glu
Ala Gln Asp Asn
Ala Gln Asn Asp
Cys Asp Ile Pro
Cys Asp Leu Pro
Cys Asp Pro Ile
Cys Asp Pro Leu
Cys Glu Pro Val
Cys Glu Val Pro
Cys Ile Asp Pro
Cys Ile Pro Asp
Cys Leu Asp Pro
Cys Leu Pro Asp
Cys Pro Asp Ile
Cys Pro Asp Leu
Cys Pro Glu Val
Cys Pro Ile Asp
Cys Pro Leu Asp
Cys Pro Val Glu
Cys Val Glu Pro
Cys Val Pro Glu
Asp Ala Asn Gln
Asp Ala Gln Asn
Asp Cys Ile Pro
Asp Cys Leu Pro
Asp Cys Pro Ile
Asp Cys Pro Leu
Asp Gly Gln Gln
Asp Ile Cys Pro
Asp Ile Pro Cys
Asp Leu Cys Pro
Asp Leu Pro Cys
Asp Asn Ala Gln
Asp Asn Gln Ala
Asp Pro Cys Ile
Asp Pro Cys Leu
Asp Pro Ile Cys
Asp Pro Leu Cys
Asp Gln Ala Asn
Asp Gln Gly Gln
Asp Gln Asn Ala
Asp Gln Gln Gly
Glu Ala Met Pro
Glu Ala Asn Asn
Glu Ala Pro Met
Glu Cys Pro Val
Glu Cys Val Pro
Glu Gly Asn Gln
Glu Gly Gln Asn
Glu Met Ala Pro
Glu Met Pro Ala
Glu Asn Ala Asn
Glu Asn Gly Gln
Glu Asn Asn Ala
Glu Asn Gln Gly
Glu Pro Ala Met
Glu Pro Cys Val
Glu Pro Met Ala
Glu Pro Val Cys
Glu Gln Gly Asn
Glu Gln Asn Gly
Glu Val Cys Pro
Glu Val Pro Cys
Gly Asp Gln Gln
Gly Glu Asn Gln
Gly Glu Gln Asn
Gly Asn Glu Gln
Gly Asn Gln Glu
Gly Gln Asp Gln
Gly Gln Glu Asn
Gly Gln Asn Glu
Gly Gln Gln Asp
Ile Cys Asp Pro
Ile Cys Pro Asp
Ile Asp Cys Pro
Ile Asp Pro Cys
Ile Pro Cys Asp
Ile Pro Asp Cys
Leu Cys Asp Pro
Leu Cys Pro Asp
Leu Asp Cys Pro
Leu Asp Pro Cys
Leu Pro Cys Asp
Leu Pro Asp Cys
Met Ala Glu Pro
Met Ala Pro Glu
Met Glu Ala Pro
Met Glu Pro Ala
Met Pro Ala Glu
Met Pro Glu Ala
Asn Ala Asp Gln
Asn Ala Glu Asn
Asn Ala Asn Glu
Asn Ala Gln Asp
Asn Asp Ala Gln
Asn Asp Gln Ala
Asn Glu Ala Asn
Asn Glu Gly Gln
Asn Glu Asn Ala
Asn Glu Gln Gly
Asn Gly Glu Gln
Asn Gly Gln Glu
Asn Asn Ala Glu
Asn Asn Glu Ala
Asn Gln Ala Asp
Asn Gln Asp Ala
Asn Gln Glu Gly
Asn Gln Gly Glu
Pro Ala Glu Met
Pro Ala Met Glu
Pro Cys Asp Ile
Pro Cys Asp Leu
Pro Cys Glu Val
Pro Cys Ile Asp
Pro Cys Leu Asp
Pro Cys Val Glu
Pro Asp Cys Ile
Pro Asp Cys Leu
Pro Asp Ile Cys
Pro Asp Leu Cys
Pro Glu Ala Met
Pro Glu Cys Val
Pro Glu Met Ala
Pro Glu Val Cys
Pro Ile Cys Asp
Pro Ile Asp Cys
Pro Leu Cys Asp
Pro Leu Asp Cys
Pro Met Ala Glu
Pro Met Glu Ala
Pro Val Cys Glu
Pro Val Glu Cys
Gln Ala Asp Asn
Gln Ala Asn Asp
Gln Asp Ala Asn
Gln Asp Gly Gln
Gln Asp Asn Ala
Gln Asp Gln Gly
Gln Glu Gly Asn
Gln Glu Asn Gly
Gln Gly Asp Gln
Gln Gly Glu Asn
Gln Gly Asn Glu
Gln Gly Gln Asp
Gln Asn Ala Asp
Gln Asn Asp Ala
Gln Asn Glu Gly
Gln Asn Gly Glu
Gln Gln Asp Gly
Gln Gln Gly Asp
Val Cys Glu Pro
Val Cys Pro Glu
Val Glu Cys Pro
Val Glu Pro Cys
Val Pro Cys Glu
Val Pro Glu Cys
Crosatoside B
A glycosylglucose derivative that is alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranose in which the anomeric hydroxy hydrogen has been replaced by a 2-(4-hydroxyphenyl)ethyl group.
Ethyl 18-bromo-8E,17E19Z-tricosatrien-4,6-diynoate
2-(4-Methoxyphenyl)ethyl 6-O-?-L-arabinopyranosyl-?-D-glucopyranoside
Ethyl 18-bromo-8E,17E,19Z-tricosatrien-4,6-diynoate
3-[[4-[benzylethylamino]phenyl]azo]-1,2-dimethyl-1H-1,2,4-triazolium methyl sulphate
C20H26N6O4S (446.17361560000006)
Fmoc-L-Homoarginine Hydrochloride Salt
C22H27ClN4O4 (446.17207320000006)
Cvt-6883
GS-6201 (CVT-6883) is a selective adenosine A2B receptor antagonist. GS-6201 displays high affinity and selectivity for the human adenosine A2B receptors (Ki=22 nM)[1]. GS-6201 reduces caspase-1 activity in the heart, and attenuates cardiac remodeling after acute myocardial infarction (AMI) in the mouse[2]. GS-62013 attenuates the airway reactivity induced by NECA, AMP, or allergen in sensitized mice[3].
(3R,3aS,4S,4aS,7R,9aR)-3-Methyl-7-nitro-1-oxo-N,N-diphenyl-1,3,3a,4,4a,5,6,7,8,9a-decahydronaphtho[2,3-c]furan-4-carboxamide
C26H26N2O5 (446.18416260000004)
(2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate
C26H26N2O5 (446.18416260000004)
(1s,2r)-2-{[(1s)-1-[(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)methyl]-3,4-Dihydroisoquinolin-2(1h)-Yl]carbonyl}cyclohexanecarboxylic Acid
C26H26N2O5 (446.18416260000004)
N-(Deoxyguanosin-8-yl)-2-aminofluorene
D009676 - Noxae > D002273 - Carcinogens
3-benzyl-4-methyl-7-[(3,4,5-trimethoxybenzyl)oxy]-2H-chromen-2-one
(2S,4R)-1-Acetyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-benzothiazolylcarbonyl)butyl]-4-hydroxy-2-pyrrolidinecarboxamide
C20H26N6O4S (446.17361560000006)
2-[2-(4-Methoxyphenyl)ethoxy]-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxane-3,4,5-triol
2-(4-methoxyphenyl)ethyl 6-O-a-L-arabinopyranosyl-b-D-glucopyranoside
(1R,2S)-2-[[(1S)-1-[(1,3-dioxo-2-isoindolyl)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-oxomethyl]-1-cyclohexanecarboxylic acid
C26H26N2O5 (446.18416260000004)
1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(E)-(3-phenylmethoxyphenyl)methylideneamino]-5-propan-2-yltriazole-4-carboxamide
N-[2-(cyclohexylthio)ethyl]-4-methyl-3-[(4-methylphenyl)sulfamoyl]benzamide
1-[3-[(E)-2-cyano-3-(furan-2-ylmethylamino)-3-oxoprop-1-enyl]-4-oxopyrido[1,2-a]pyrimidin-2-yl]piperidine-4-carboxamide
(1S,5R)-3-{[(6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-3-yl)oxy]acetyl}-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one
C26H26N2O5 (446.18416260000004)
2-[[2-(5-chloro-2-methoxyanilino)-2-oxoethyl]-methylamino]-N-[2-(4-morpholinyl)phenyl]acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2S,5R,6S)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2R,5S,6R)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2S,5S,6S)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2S,5S,6R)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2S,5R,6R)-5-[(4-chlorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-2-pyridin-2-ylacetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2R,5R,6R)-5-[(4-chlorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-2-pyridin-2-ylacetamide
C22H27ClN4O4 (446.17207320000006)
(2R)-2-[(4S,5S)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
(2S)-2-[(4R,5R)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
N-[2-[(2R,5R,6S)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
(1S,2aS,8bS)-N-(3-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(2-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1R,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(3-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1S,2aS,8bS)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(3-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6R,7S,8R)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6S,7R,8S)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6S,7S,8S)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6R,7S,8S)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6R,7R,8S)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(2R)-2-[(4R,5R)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
(2S)-2-[(4S,5S)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
N-[2-[(2R,5S,6S)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
(1S,2aR,8bR)-N-(3-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(2-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1R,2aR,8bR)-N-(3-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(2-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1R,2aS,8bS)-N-(3-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(2-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1R,2aS,8bS)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(3-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1S,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(3-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6R,7S,8S)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6R,7R,8R)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6R,7R,8S)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6S,7S,8R)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6S,7R,8R)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6R,7S,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6S,7S,8S)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6S,7S,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6R,7R,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6S,7R,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
1-[2-({5-amino-1-[(1-carboxylato-2-hydroxyethyl)-c-hydroxycarbonimidoyl]pentyl}-c-hydroxycarbonimidoyl)-3,4-dihydroxyphenyl]-1λ⁵-pyridin-1-ylium
(2r,3r,4s)-2,3,10,10-tetramethyl-6-oxo-8-phenyl-3,4-dihydro-2h-1,5,9-trioxatriphenylen-4-yl acetate
(2s,3r,4s,5s,6r)-2-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-phenoxyoxan-3-yl]oxy}-2-ethyl-6-(hydroxymethyl)oxane-3,4,5-triol
2-[(4-methoxyphenyl)methoxy]-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxane-3,4,5-triol
(2s,3s,4r,5r,6s)-2-[(4-methoxyphenyl)methoxy]-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxane-3,4,5-triol
3-chloro-2-(3,7-dimethylocta-2,6-dien-1-yl)-2,5,7-trihydroxy-3-(3-methylbut-2-en-1-yl)naphthalene-1,4-dione
5-butoxy-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid
ethyl (8e,17e,19e)-18-bromotricosa-8,17,19-trien-4,6-diynoate
(2r,3r,4s,5s,6r)-2-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-(2-phenylethoxy)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-methyl-6-{[3,4,5-trihydroxy-6-(2-hydroxy-2-phenylethoxy)oxan-2-yl]methoxy}oxane-3,4,5-triol
1-(1-hydroxyethyl)-4β-rutinosyloxybenzene
{"Ingredient_id": "HBIN000442","Ingredient_name": "1-(1-hydroxyethyl)-4\u03b2-rutinosyloxybenzene","Alias": "NA","Ingredient_formula": "C20H30O11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10105","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-hydroxyphenylethyl 4-o-β-d-glucopyranosyl-(1→3)-o-α-l-rhamnopyranoside
{"Ingredient_id": "HBIN010566","Ingredient_name": "4-hydroxyphenylethyl 4-o-\u03b2-d-glucopyranosyl-(1\u21923)-o-\u03b1-l-rhamnopyranoside","Alias": "NA","Ingredient_formula": "C20H30O11","Ingredient_Smile": "CC1C(C(C(C(O1)OC2=CC=C(C=C2)CCO)O)OC3C(C(C(C(O3)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10619","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-[(8r,16s,24r)-1,9,17-triazahexacyclo[14.8.0.0²,⁷.0⁸,¹⁷.0¹⁰,¹⁵.0¹⁸,²³]tetracosa-2,4,6,10,12,14,18,20,22-nonaen-24-ylamino]benzoic acid
(2s,3r)-3-chloro-2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,5,7-trihydroxy-3-(3-methylbut-2-en-1-yl)naphthalene-1,4-dione
2-{[4,5-dihydroxy-6-(hydroxymethyl)-2-(2-phenylethoxy)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
6,8-dihydroxy-3-[(1z)-2-[8-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-5-yl]ethenyl]isochromen-1-one
(2r,3r,4r)-2,3,10,10-tetramethyl-6-oxo-8-phenyl-3,4-dihydro-2h-1,5,9-trioxatriphenylen-4-yl acetate
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(2-phenylethoxy)oxan-2-yl]methoxy}oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-[(2-methylphenyl)methoxy]-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
2-(hydroxymethyl)-6-{[3,4,5-trihydroxy-6-(2-phenylethoxy)oxan-2-yl]methoxy}oxane-3,4,5-triol
(1r,4s,7s,10s,19s)-4-(1h-indol-3-ylmethyl)-9,9-dimethyl-6,15,17-trioxa-3-azapentacyclo[11.5.1.0¹,¹⁰.0²,⁷.0¹⁶,¹⁹]nonadeca-2,12-diene-5,18-dione
C26H26N2O5 (446.18416260000004)
(2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(4-hydroxyphenyl)methyl]-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(2s,3r,4s,5s,6r)-2-{[(3s)-5-chloro-8-hydroxy-7-methyl-3-pentyl-3,4-dihydro-1h-2-benzopyran-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl hexanoate
C26H26N2O5 (446.18416260000004)
(6ar,8s,9s,9as)-9-acetyl-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-8-methoxy-6a,8-dimethyl-9h,9ah-furo[2,3-h]isochromen-6-one
(2s,3r,4s,5s,6r)-2-(3,4-dimethylphenoxy)-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(6ar,8r,9s,9as)-9-acetyl-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-8-methoxy-6a,8-dimethyl-9h,9ah-furo[2,3-h]isochromen-6-one
4-(1h-indol-3-ylmethyl)-9,9-dimethyl-6,15,17-trioxa-3-azapentacyclo[11.5.1.0¹,¹⁰.0²,⁷.0¹⁶,¹⁹]nonadeca-2,12-diene-5,18-dione
C26H26N2O5 (446.18416260000004)
9-acetyl-5-chloro-3-(3,5-dimethylhepta-1,3-dien-1-yl)-8-methoxy-6a,8-dimethyl-9h,9ah-furo[2,3-h]isochromen-6-one
methyl 1-(acetyloxy)-3-hydroxy-1-methyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3,3a,6,7,7a-hexahydroindene-4-carboxylate
2-({3,5-dihydroxy-2-[4-(2-hydroxyethyl)phenoxy]-6-methyloxan-4-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4r,5r,6r)-2-methyl-6-{[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-[(2r)-2-hydroxy-2-phenylethoxy]oxan-2-yl]methoxy}oxane-3,4,5-triol
(19s)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl hexanoate
C26H26N2O5 (446.18416260000004)